Connect with us

Headlines

Novartis CEO: Alcon Spinoff Could Be ‘Big Opportunity’ for Shareholders

mm

Published

on

Alcon’s sales fell 3 percent in 2016.

The CEO of Novartis said the company continues to mull the possibility of spinning off its Alcon eyecare unit.

Such a move would likely “create a big opportunity for our shareholders,” CEO Joe Jimenez said, according to MarketWatch.

The company anticipates having a decision by the end of the year, the website reports.

Joerg Reinhardt, chairman of Novartis, said in November 2016 that it was possible the pharmaceutical company would sell Alcon. A planned turnaround at Alcon hasn’t progressed as quickly as Novartis officials had hoped.

Advertisement

Bloomberg reports that a spinoff and an initial public offering are among the options being considered for Alcon.

Jimenez told Bloomberg: “Now is the time for us to take a look at what’s in the best interests of Novartis shareholders for that unit. This is going to include all options, including retaining the business to exiting the business.”

Alcon, whose U.S. headquarters are in Texas, makes items including contact care products, ophthalmic pharmaceuticals, dry eye products and ocular vitamins. Novartis took ownership of the company through several deals totaling $51 billion.

According to Bloomberg,  Alcon’s sales fell 3 percent in 2016 to just over $5.8 billion.

Read more at MarketWatch and Bloomberg

Advertisement

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Most Popular